|Day Low/High||33.44 / 34.45|
|52 Wk Low/High||27.88 / 43.08|
Aggressive traders who have dug into the fundamentals of this German-based company could look to go long.
Let's head to the oil patch for a look at Chevron and Pioneer Natural Resources.
* Yesterday may have represented a classic "sell on the good news" * While many were cheering about the vaccine news, I was waiting to sell, red tickets in hand * Some stocks and sectors had a great year yesterday * And some stocks and sectors got s...
What the Nasdaq experienced Monday is known not just as an 'Outside Day,' but an 'Outside Reversal,' and these can be dangerous.
The Russell 2000 outperformed the Nasdaq by 5.2 percentage points on Monday -- the largest outperformance ever recorded between the two indices.
The sloppy day wasn't nearly as positive as you'd think based on the action in the Dow and S&P 500, and the question now is what comes next?
We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.
Here's how to position yourself now that news of the Pfizer vaccine has landed, and what's happening with the 'haves,' 'have nots' and Treasuries.
This is a very extended market that is now even more extended.
When the dust settles midweek, I believe we'll have a great feel for the longer-term outlook associated with the Pfizer news.
Monday's vaccine news may well further improve the charts technically.
The leaders now are suddenly the reopening stocks, while the work remotely and stay at home stocks are being sold.
The vaccine news marks a major turning point and the issue now is to navigate this rotation.
Let's take a look amid the announcement that Pfizer's Covid-19 vaccine has progressed further.
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.
The 'work from home' or 'economic lockdown' trade is close to being back on.
This is a major earnings week, electoral risk is real, the virus is already slowing velocity, and the cavalry (fiscal policy) is not coming. Sometimes, circling the wagons is not the worst idea.
There is no stimulus deadline. There is no deal. There are only the games people play.
Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?
Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.
One day after deciding that we still could not confirm the market's uptrend, we are forced to ask the opposite.
Suddenly, both sides realize that they have played politics and the people had noticed. Not those two from Tuesday night. Thankfully.
Neither candidate seems to be the enemy of the market -- at least not yet.